Lack of Asymmetry of Nigrostriatal Dopaminergic Function in Healthy Subjects
Sign Up to like & getrecommendations! Published in 2020 at "Movement Disorders"
DOI: 10.1002/mds.28019
Abstract: In right‐handed patients with Parkinson's disease (PD) or isolated rapid eye movement sleep behavior disorder, dopamine transporter (DAT) [(123)I]β‐carboxymethyoxy‐3‐β‐(4‐iodophenyl) tropane single photon emission computed tomography (SPECT) shows predominant nigrostriatal deficit in the left striatum. This… read more here.
Keywords: nigrostriatal dopaminergic; lack asymmetry; asymmetry nigrostriatal; function healthy ... See more keywords
Early Postnatal Exposure to Paraquat and Maneb in Mice Increases Nigrostriatal Dopaminergic Susceptibility to a Re-challenge with the Same Pesticides at Adulthood: Implications for Parkinson’s Disease
Sign Up to like & getrecommendations! Published in 2019 at "Neurotoxicity Research"
DOI: 10.1007/s12640-019-00097-9
Abstract: Exposure to environmental contaminants represents an important etiological factor in sporadic Parkinson’s disease (PD). It has been reported that PD could arise from events that occur early in development and that lead to delayed adverse… read more here.
Keywords: nigrostriatal dopaminergic; paraquat maneb; exposure; early postnatal ... See more keywords
Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/srep45741
Abstract: Clinical studies report significant increases in acrolein (an α,β-unsaturated aldehyde) in the substantia nigra (SN) of patients with Parkinson’s disease (PD). In the present study, acrolein-induced neurotoxicity in the nigrostriatal dopaminergic system was investigated by… read more here.
Keywords: nigrostriatal dopaminergic; acrolein induced; synuclein aggregation; dopaminergic system ... See more keywords